Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 22 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
NCT06580314
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +21 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
NCT04919629
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT05415709
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +47 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT06639074
- Conditions
- Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma, Advanced Ovarian Carcinoma, +15 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT00951496
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine System Diseases, +55 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
NCT02713386
- Conditions
- Adnexal Diseases, FIGO Stage III Ovarian Cancer 2014, FIGO Stage IIIA Ovarian Cancer 2014, +35 more
- Locations
-
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Sutter Auburn Faith Hospital Auburn, California, United States
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Sutter Roseville Medical Center Roseville, California, United States
NCT02020707
- Conditions
- Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma, +45 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT01097746
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +48 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson Regional Care Center-Katy Houston, Texas, United States
- MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States
- MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States
NCT00888615
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +39 more
- Locations
-
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- John Muir Medical Center-Concord Campus Concord, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California San Diego San Diego, California, United States
NCT00989651
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +59 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of Colorado Hospital Aurora, Colorado, United States
- Augusta University Medical Center Augusta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT02853318
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +28 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01504126
- Conditions
- Adnexal Diseases, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Diseases, +44 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Lyndon Baines Johnson General Hospital Houston, Texas, United States
- M D Anderson Cancer Center Houston, Texas, United States
- The Woman's Hospital of Texas Houston, Texas, United States
NCT01074411
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +41 more
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT00262847
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +48 more
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Clearview Cancer Institute Huntsville, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
NCT04092270
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +43 more
- Locations
-
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
NCT02068794
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +39 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT03587311
- Conditions
- Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, +5 more
- Locations
-
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
NCT02502266
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
NCT01167712
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine System Diseases, +50 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
NCT02345265
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States